Related references
Note: Only part of the references are listed.Pathologist Agreement Rates of PD-L1 Tumor and Immune Cell Quantitation Using Digital Read, Field-Of-View, and Whole Tumor Image Analysis
Michael Barnes et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features
Kun-Hsing Yu et al.
NATURE COMMUNICATIONS (2016)
External quality assessment for immunohistochemistry: experiences from NordiQC
S. Nielsen
BIOTECHNIC & HISTOCHEMISTRY (2015)
Standardization of Diagnostic Immunohistochemistry Literature Review and Geisinger Experience
Fan Lin et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2014)
Laboratory Compliance With the American Society of Clinical Oncology/College of American Pathologists Human Epidermal Growth Factor Receptor 2 Testing Guidelines A 3-Year Comparison of Validation Procedures
Kathryn S. Dyhdalo et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2014)
Overview of Automated Immunohistochemistry
Jeffrey W. Prichard
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2014)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2014)
Principles of Analytic Validation of Immunohistochemical Assays Guideline From the College of American Pathologists Pathology and Laboratory Quality Center
Patrick L. Fitzgibbons et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2014)
Standardization of Negative Controls in Diagnostic Immunohistochemistry: Recommendations From the International Ad Hoc Expert Panel
Emina E. Torlakovic et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2014)
lnterobserver Concordance in Implementing the 2010 ASCO/CAP Recommendations for Reporting ER in Breast Carcinomas A Demonstration of the Difficulties of Consistently Reporting Low Levels of ER Expression by Manual Quantification
Emily S. Reisenbichler et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)
External Quality Assessment (EQA) program for the preanalytical and analytical immunohistochemical determination of HER2 in breast cancer: an experience on a regional scale
Irene Terrenato et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
Digital Imaging in Pathology: Whole-Slide Imaging and Beyond
Farzad Ghaznavi et al.
Annual Review of Pathology-Mechanisms of Disease (2011)
Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
Mitch Dowsett et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Facilitating consensus by examining patterns of treatment effects
Richard D. Gelber et al.
BREAST (2009)
Implementation of a Canadian External Quality Assurance Program for Breast Cancer Biomarkers An Initiative of Canadian Quality Control in Immunohistochemistry (cIQc) and Canadian Association of Pathologists (CAP) National Standards Committee/Immunohistochemistry
Jefferson Terry et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2009)
Estrogen- and progesterone-receptor status in ECOG 2197: Comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory
Sunil S. Badve et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer
Elton Rexhepaj et al.
BREAST CANCER RESEARCH (2008)
Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer:: BIG 1-98
Giuseppe Viale et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Molecular markers for predicting response to tamoxifen in breast cancer patients
DR Ciocca et al.
ENDOCRINE (2000)
Share Paper
